Tandem Diabetes Care, Inc. (TNDM) Social Stream
TANDEM DIABETES CARE INC (TNDM) Price Targets From Analysts
Use the tables below to see what analysts covering TANDEM DIABETES CARE INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 10 | $154 | $90 | $127.3 | $47.32 | 169.02% |
| 2021-12-06 | 9 | $154 | $90 | $127 | $47.32 | 168.39% |
| 2021-12-19 | 7 | $170 | $90 | $133.5 | $47.32 | 182.12% |
| 2022-02-23 | 8 | $170 | $90 | $136.444 | $47.32 | 188.34% |
| 2022-02-24 | 8 | $170 | $90 | $135.375 | $47.32 | 186.08% |
| 2022-03-01 | 7 | $170 | $90 | $134.777 | $47.32 | 184.82% |
| 2022-05-06 | 9 | $160 | $90 | $126.666 | $47.32 | 167.68% |
| 2022-05-17 | 9 | $160 | $90 | $123.6 | $47.32 | 161.2% |
| 2022-08-05 | 7 | $150 | $72 | $97.6 | $47.32 | 106.26% |
| 2022-08-13 | 7 | $150 | $49 | $94.3 | $47.32 | 99.28% |
| 2022-09-19 | 7 | $150 | $49 | $92.8 | $47.32 | 96.11% |
The Trend in the Analyst Price Target
TNDM's average price target has moved down $43.64 over the prior 30 weeks.
Over the past 45 weeks, TNDM's average upside potential has been 35.81%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-23 | 8 | 170 | 90 | 136.444 | 104.20 | 30.94% |
| 2022-02-24 | 8 | 170 | 90 | 135.375 | 110.20 | 22.84% |
| 2022-05-06 | 9 | 160 | 90 | 122.888 | 76.00 | 61.69% |
| 2022-05-17 | 9 | 160 | 100 | 127.333 | 74.71 | 70.44% |
| 2022-08-13 | 7 | 150 | 49 | 94.300 | 53.89 | 74.99% |
TNDM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.29 | 3 | 1 | 2 | 1 | 1 | 7 |
The Trend in the Broker Recommendations
Over the past 26 months, TNDM's average broker recommendation rating worsened by 0.42.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- TANDEM DIABETES CARE INC's average analyst price target is greater than 1902.49% of all US stocks.
- In terms of how TANDEM DIABETES CARE INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1866.07% of that group.
- TANDEM DIABETES CARE INC's variance in analysts' estimates is lower than -1668.42% of Medical Equipment stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, TANDEM DIABETES CARE INC's number of analysts covering the stock is higher than 1472.1% of them.
In the Medical Equipment industry, SWAV, SKIN, and SILK are the three stocks most similar to TANDEM DIABETES CARE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is TNDM a Buy, Hold or Sell? See the POWR Ratings now!